Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Dynavax Adjuvanted Clover Bio's COVID-19 Vaccine Booster Shows Durable Protection Against Omicron

  • Clover Biopharmaceuticals Ltd's follow-up analysis for efficacy in the SPECTRA Phase 2/3 trial of SCB-2019 COVID-19 vaccine provided high and durable protection in individuals five months after the second dose. 
  • The follow-up analysis involved 26,400 individuals.
  • Against any variant, efficacy was maintained at 100% against severe COVID-19 and 95% against COVID-19 associated hospitalizations at five months after the second dose in the primary vaccination setting. 
  • Additionally, there was no evidence that clinical efficacy declined over five months in individuals with prior infection who were subsequently boosted with SCB-2019.
  • Clover's COVID-19 vaccine candidate combines Dynavax Technologies Corporation's (NASDAQ:DVAX) CpG 1018 advanced adjuvant and aluminum hydroxide (alum).
  • A heterologous booster dose of SCB-2019 in individuals previously receiving two doses of AstraZeneca plc (NASDAQ:AZN) COVID-19 vaccine induced approximately 2-fold higher levels of neutralizing antibodies against the omicron variant compared to individuals receiving three doses of AstraZeneca's vaccine.
  • A homologous booster dose of SCB-2019 in individuals with prior COVID-19 infection induced multi-fold higher levels of neutralizing antibodies against the omicron variant than individuals receiving three doses of AstraZeneca's COVID-19 vaccine.
  • The submissions are anticipated to complete in mid-2022 for the China NMPA and by Q3 of 2022 for the WHO and EMA.
  • Price Action: DVAX shares are up 3.10% at $11.31 during the premarket session on the last check Thursday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.